SCHEMBL5264294

SCHEMBL5264294

CC(C)CNC(=O)NS(=O)(=O)c1cccc(N)c1

nearest known ligand 0.55

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.55
FBP1 P09467 15/20 0.51
LARS1 Q9P2J5 3/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19332530 0.82 CA2 (0.51) FBP1
SCHEMBL2009157 0.81 FBP1 (0.72) FBP1
SCHEMBL387144 0.80 FBP1 (0.74) CYP2C9FBP1
SCHEMBL5032592 0.80 CYP19A1 (0.60)
SCHEMBL8589883 0.79 ALDH1A1 (0.67) FBP1LARS1
SCHEMBL6297904 0.76 TSHR (0.64) FBP1
SCHEMBL8541021 0.76 FBP1 (0.51) FBP1
SCHEMBL15054822 0.76 F2 (0.51) FBP1
SCHEMBL13996548 0.76 CYP2C9 (0.70) CYP2C9
SCHEMBL5050574 0.75 F2 (0.61) FBP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599468-B1 1,2,3-TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO SUCH AS DIABETES AND HYPERGLYCEMIA ARENA PHARM INC (US) 2007-10-03 EP disclosed